| Literature DB >> 35887867 |
Patricia Alexandra García-Garro1, Agustín Aibar-Almazán2, Yulieth Rivas-Campo1, Gloria Cecilia Vega-Ávila1, Diego Fernando Afanador-Restrepo1, Fidel Hita-Contreras2.
Abstract
The COVID-19 pandemic has had a strong influence on people's quality of life, and the different restrictive measures during the phases of the pandemic have had consequences for physical and mental health. This study determined the changes in health-related quality of life (HRQoL), sleep quality, depression symptoms (DS), and physical activity (PA) level of middle-aged Colombian university personnel during the COVID-19 pandemic. The analysis was performed following a longitudinal design on a sample of 354 people at four points before and during the pandemic. The International Physical Activity Questionnaire (IPAQ), the SF-12v2, the Pittsburgh Sleep Quality Index (PSQI), and the Zung Self-Rating Depression Scale (ZSDS) were included in an online survey. The measurements showed a decrease in quality of life with respect to PCS from 91.66 ± 10.78 to 83.64 ± 17.22 (p = 0.000) and MCS from 87.57 ± 12.23 to 80.90 ± 17.31, while poor sleep quality increased from 25.99% to 47.46% (p = 0.000), with DS reaching the peak during mandatory confinement (14.69%). Regarding the level of physical activity, the period of mandatory confinement inverted the proportion, highlighting active people as a minority (32.2%). In the multivariate analysis, we adjusted for age, sex, BMI, and socioeconomic level, discarding confounding effects and their interactions with the results obtained. In conclusion, this study showed that the pandemic has had a negative impact on sleep quality, HRQoL, DS, and PA level.Entities:
Keywords: COVID-19; depressive symptoms; lockdown; physical activity; quality of life; sleep quality
Year: 2022 PMID: 35887867 PMCID: PMC9322187 DOI: 10.3390/jcm11144104
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Flow chart of the study participants.
Descriptive data of the participants (n = 354).
| Overall Participants ( | |||
|---|---|---|---|
| Age, mean (SD) | 43.39 (10.21) | ||
| Sex, | Male | 209 (59.04) | |
| Female | 145 (40.96) | ||
| * BMI, | Underweight | 3 (0.85) | |
| Normal range | 132 (37.29) | ||
| Overweight | 175 (49.44) | ||
| Pre-obese | 30 (8.47) | ||
| Obese class 1 | 7 (1.98) | ||
| Obese class 2 | 7 (1.98) | ||
| Obese class 3 | 0 (0.00) | ||
| Marital status, | Single/free union | 196 (55.37) | |
| Married | 122 (34.46) | ||
| Separated/widowed | 36 (10.16) | ||
| Residence, | Rural area | 48 (13.56) | |
| Urban area | 306 (86.44) | ||
| ** Socioeconomic stratum, | 1 | 20 (5.65) | |
| 2 | 54 (15.25) | ||
| 3 | 113 (31.92) | ||
| 4 | 115 (32.49) | ||
| 5 | 47 (13.28) | ||
| 6 | 5 (1.41) | ||
| Children, | No | 120 (33.90) | |
| Yes | 234 (66.10) | ||
| Smoker, | No | 339 (95.76) | |
| Yes | 15 (4.24) | ||
| Alcohol consumption, | No | 129 (36.44) | |
| Yes | 225 (63.56) | ||
| Occasionally | 211 (59.60) | ||
| Frequently | 14 (3.96) | ||
| Diagnosis with COVID-19, | No | 349 (98.59) | |
| Yes | 5 (1.41) | ||
| *** Living with people at risk of COVID-19, | No | 237 (66.95) | |
| Yes | 117 (33.05) | ||
BMI (kg/m2): body mass index; IPAQ: International Physical Activity Questionnaire. * According to the WHO classification. ** According to Law 142 of 1994 that establishes the Regime of Domiciliary Public Services in Colombia. SD: standard deviation. *** Housemates or family members with high risk of contracting COVID-19 or are at risk of developing severe or fatal COVID-19.
Figure A1Changes in PCS, MCS, sleep quality, BP and depressive symptoms at different data points. T0: period before the pandemic; T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation; PCS: physical health component summary; MCS: mental health component summary.
Cronbach’s alpha reliability coefficients of the instruments at the different measurement times.
| T0 ( | T1 ( | T2 ( | T3 ( | |
|---|---|---|---|---|
| SF-12v2 | 0.77 | 0.79 | 0.78 | 0.82 |
| PSQI | 0.81 | 0.80 | 0.80 | 0.84 |
| ZSDS | 0.75 | 0.73 | 0.72 | 0.71 |
T0: period before the pandemic; T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation; SF-12v2: 12-Item Short-Form Health Survey. PSQI: Pittsburgh Sleep Quality Index; ZSDS: Zung Self-Rating Depression Scale.
ANOVA repeated measures. Differences between measurement times for quantitative variables: HRQoL and sleep quality.
| T0 ( | T1 ( | T2 ( | T3 ( |
|
|
| Effect Size | ||
|---|---|---|---|---|---|---|---|---|---|
| SF-12v2, mean (SD) | Physical functioning | 94.84 (13.95) | 89.90 (21.17) | 89.01 (18.75) | 91.52 (17.93) | 3 | 6.68 | 0.0002 | 0.77 |
| Physical role | 93.92 (20.22) | 79.66 (37.39) | 88.57 (27.65) | 83.62 (32.77) | 3 | 14.38 | 0.0000 | 0.94 | |
| Bodily pain | 94.84 (12.04) | 88.48 (19.64) | 91.07 (16.00) | 90.22 (16.50) | 3 | 9.41 | 0.0000 | 0.56 | |
| General health | 83.02 (16.33) | 76.53 (16.78) | 74.21 (17.96) | 77.78 (17.46) | 3 | 15.72 | 0.0000 | 0.92 | |
| PCS | 91.66 (10.78) | 83.64 (17.22) | 85.71 (14.16) | 85.78 (14.97) | 3 | 19.85 | 0.0000 | 0.95 | |
| Vitality | 84.29 (16.88) | 75.81 (20.92) | 75.92 (20.36) | 77.93 (22.04) | 3 | 13.80 | 0.0000 | 0.91 | |
| Social functioning | 89.12 (20.31) | 86.51 (21.69) | 85.80 (22.23) | 85.05 (22.95) | 3 | 1.95 | 0.1199 | 0.20 | |
| Emotional role | 94.77 (18.65) | 85.45 (32.26) | 89.28 (27.94) | 84.77 (32.88) | 3 | 8.35 | 0.0000 | 0.76 | |
| Mental health | 82.11 (16.20) | 75.84 (18.75) | 80.46 (18.33) | 79.25 (19.14) | 3 | 7.64 | 0.0000 | 0.53 | |
| MCS | 87.57 (12.23) | 80.90 (17.31) | 82.87 (16.46) | 81.75 (19.46) | 3 | 11.47 | 0.0000 | 0.69 | |
| PSQI, mean (SD). | Sleep quality domain | 0.54 (0.61) | 0.73 (0.69) | 0.67 (0.63) | 0.71 (0.70) | 3 | 5.66 | 0.0008 | 0.57 |
| Sleep latency domain | 0.60 (0.80) | 1.05 (1.10) | 0.84 (0.96) | 0.87 (1.02) | 3 | 12.86 | 0.0000 | 0.89 | |
| Sleep duration domain | 0.90 (0.88) | 1.09 (0.97) | 1.17 (0.92) | 1.18 (0.94) | 3 | 5.89 | 0.0005 | 0.55 | |
| Sleep efficiency domain | 0.05 (0.30) | 0.18 (0.54) | 0.11 (0.43) | 0.17 (0.56) | 3 | 5.45 | 0.0010 | 0.72 | |
| Sleep disturbances domain | 0.71 (0.54) | 0.84 (0.64) | 0.80 (0.60) | 0.89 (0.63) | 3 | 4.24 | 0.0054 | 0.64 | |
| Use of sleeping medication domain | 0.05 (0.41) | 0.12 (0.63) | 0.10 (0.53) | 0.13 (0.61) | 3 | 1.23 | 0.2983 | 0.18 | |
| Daytime dysfunction domain | 0.37 (0.57) | 0.50 (0.66) | 0.45 (0.63) | 0.56 (0.71) | 3 | 4.47 | 0.0040 | 0.59 | |
| Total score for PSQI | 3.25 (2.76) | 4.54 (3.80) | 4.17 (3.22) | 4.55 (3.78) | 3 | 10.50 | 0.0000 | 0.86 |
T0: period before the pandemic. T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation. SF-12v2: 12-Item Short-Form Health Survey; HRQoL: health-related quality of life PCS: physical health component summary; MCS: mental health component summary; PSQI: Pittsburgh Sleep Quality Index; ZSDS: Zung Self-Rating Depression Scale; DS: depressive symptoms; IPAQ: International Physical Activity Questionnaire; SD: standard deviation. Cohen’s d (d) = effect size.
Differences between measurement times for sleep quality, depression and PA level (dichotomized variables).
| T0 ( | T1 ( | T2 ( | T3 ( | χ2 |
|
| Cramer’s V | |||
|---|---|---|---|---|---|---|---|---|---|---|
| PSQI, | Without LSQ | 262 (74.01) | 186 (52.54) | 163 (58.21) | 95 (54.60) | 39.60 | 0.000 | 3 | 0.201 | |
| Sleep Quality | With LSQ | 92 (25.99) | 168 (47.46) | 117 (41.79) | 79 (45.40) | |||||
| ZSDS, | Without DS | 328 (92.66) | 302 (85.31) | 250 (89.29) | 159 (91.38) | 10.93 | 0.012 | 3 | 0.097 | |
| Depression | With DS | 26 (7.34) | 52 (14.69) | 30 (10.71) | 15 (8.62) | |||||
| IPAQ, n (%). | Insufficiently active | Low | 78 (22.03) | 240 (67.80) | 140 (50.00) | 66 (37.93) | 155.91 | 0.000 | 3 | 0.366 |
| PA level | Active | 276 (77.97) | 114 (32.20) | 140 (50.00) | 108 (62.07) | |||||
| Moderate | 128 (36.16) | 76 (21.47) | 86 (30.71) | 51 (29.31) | ||||||
| High | 148 (41.81) | 38 (10.73) | 54 (19.29) | 57 (32.76) | ||||||
| SF12v2HRQoL | Below average | 350 (98.87) | 339 (95.76) | 275 (98.21) | 163 (93.68) | 14.07 | 0.000 | 3 | 0.11 | |
| Above average | 4 (1.13) | 15 (4.24) | 5 (1.79) | 11 (6.32) |
T0: period before the pandemic; T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation. PSQI: Pittsburgh Sleep Quality Index; LSQ: low sleep quality; DS: depressive symptoms; ZSDS: Zung Self-Rating Depression Scale; IPAQ: International Physical Activity Questionnaire. PA: physical activity. HRQoL: health-related quality of life; PCS: physical health component summary; MCS: mental health component summary.
Analysis of covariance of the sleep quality and health-related quality of life adjusted for sociodemographic conditions.
| Source |
|
|
| |
|---|---|---|---|---|
| Total Score PSQI | Model | 48 | 3.43 | 0.000 |
| Age | 1 | 4.71 | 0.391 | |
| Sex | 1 | 0.00 | 0.954 | |
| Socioeconomic stratum | 5 | 3.56 | 0.203 | |
| Marital status | 4 | 1.15 | 0.332 | |
| Alcohol consumption | 4 | 4.77 | 0.121 | |
| Smoker | 1 | 13.17 | 0.000 | |
| BMI | 5 | 0.87 | 0.500 | |
| Diagnosis with COVID-19 | 1 | 0.15 | 0.697 | |
| Living with people at risk of COVID-19 | 1 | 0.49 | 0.486 | |
| SF-12v2. | Model | 29 | 5.06 | 0.000 |
| Age | 1 | 2.94 | 0.087 | |
| Sex | 1 | 27.90 | 0.159 | |
| Socioeconomic stratum | 5 | 1.04 | 0.391 | |
| Marital status | 4 | 1.58 | 0.177 | |
| Alcohol consumption | 4 | 1.13 | 0.340 | |
| Smoker | 1 | 0.75 | 0.386 | |
| BMI | 5 | 4.86 | 0.202 | |
| Diagnosis with COVID-19 | 1 | 1.86 | 0.173 | |
| Living with people at risk of COVID-19 | 1 | 0.59 | 0.441 |
PSQI: Pittsburgh Sleep Quality Index; SF-12v2: 12-Item Short-Form Health Survey; BMI (kg/m2): body mass index; HRQoL: health-related quality of life.
Multivariate regression post MANOVA.
| Measurement Time | Coef. |
| [95% Confidence Interval] | |
|---|---|---|---|---|
| PCS | T0 | 91.66 | 0.000 | 90.15–93.16 |
| T1 | −8.01 | 0.000 | −10.13–−5.88 | |
| T2 | −5.94 | 0.000 | −8.20–−3.68 | |
| T3 | −5.87 | 0.000 | −8.49–−3.25 | |
| MCS | T0 | 87.57 | 0.000 | 85.89–89.25 |
| T1 | −6.67 | 0.000 | −9.04–−4.29 | |
| T2 | −4.70 | 0.000 | −7.23–−2.18 | |
| T3 | −5.82 | 0.000 | −8.74–−2.90 | |
| Total Score PSQI | T0 | 3.25 | 0.000 | 2.90–3.60 |
| T1 | 1.29 | 0.000 | 0.79–1.78 | |
| T2 | 0.91 | 0.001 | 0.38–1.44 | |
| T3 | 1.29 | 0.000 | 0.68–1.91 |
T0: period before the pandemic; T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation; PCS: physical health component summary; MCS: mental health component summary; PSQI: Pittsburgh Sleep Quality index.
Logistic regressions: associations of time with dichotomized outcomes.
| Measurement Time | Odds Ratio |
| [95% Confidence Interval] | |
|---|---|---|---|---|
| IPAQ | T0 | 0.35 | 0.000 | 2.75–4.54 |
| T1 | 0.13 | 0.000 | 0.09–0.18 | |
| T2 | 0.28 | 0.000 | 0.20–0.39 | |
| T3 | 0.46 | 0.000 | 0.31–0.68 | |
| PSQI | T0 | 0.35 | 0.000 | 0.27–0.44 |
| T1 | 2.57 | 0.000 | 1.87–3.52 | |
| T2 | 2.04 | 0.000 | 1.46–2.86 | |
| T3 | 2.36 | 0.000 | 1.61–3.46 | |
| ZSDS | T0 | 0.08 | 0.000 | 0.05–0.11 |
| T1 | 2.17 | 0.002 | 1.32–3.56 | |
| T2 | 1.51 | 0.140 | 0.87–2.62 | |
| T3 | 1.19 | 0.607 | 0.61–2.30 | |
| SF12v2 | T0 | 0.01 | 0.000 | 0.004–0.03 |
| T1 | 0.87 | 0.117 | 0.78–11–7 | |
| T2 | 1.59 | 0.492 | 0.42–5.98 | |
| T3 | 5.90 | 0.003 | 1.85–18.82 |
T0: period before the pandemic; T1: mandatory preventive isolation; T2: selective isolation and responsible individual distancing; T3: selective isolation with responsible individual distancing and safe economic reactivation; IPAQ: International Physical Activity Questionnaire; PSQI: Pittsburgh Sleep Quality Index; ZSDS: Zung Self-Rating Depression Scale.